2022-09-21The incidence of patients under 55 years old diagnosed with Prostate Cancer (EO-PCa) has increased during recent years. The molecular biology of PCa cancer in this group of patients remains unclear. Here, we applied weighted gene coexpression network analysis of the expression of miRNAs from 24 EO-PCa patients (38–45 years) and 25 late-onset PCa patients (LO-PCa, 71–74 years) to identify key miRNAs in EO-PCa patients. In total, 69 diferentially expressed miRNAs were identifed. Specifcally, 26 and 14 miRNAs were exclusively deregulated in young and elderly patients, respectively, and 29 miRNAs were shared. We identifed 20 hub miRNAs for the network built for EO-PCa. Six of these hub miRNAs exhibited prognostic signifcance in relapse‐free or overall survival. Additionally, two of the hub miRNAs were coexpressed with mRNAs of genes previously identifed as deregulated in EO-PCa and in the most aggressive forms of PCa in African-American patients compared with Caucasian patients. These genes are involved in activation of immune response pathways, increased rates of metastasis and poor prognosis in PCa patients. In conclusion, our analysis identifed miRNAs that are potentially important in the molecular pathology of EO-PCa. These genes may serve as biomarkers in EO-PCa and as possible therapeutic targets.202014 p.application/pdfArtículo de revista2022-09-212045-2322https://repositorio.fucsalud.edu.co/handle/001/3165enginfo:eu-repo/semantics/openAccessAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)Prostatic NeoplasmsMicroARNsBiomarkersGenesMolecular biologyPatientsSurvivorshipNeoplasias de la PróstataBiomarcadoresBiología molecularPacientesSupervivenciahttp://purl.org/coar/access_right/c_abf2